References
- National Cancer Information Center (Korea). Cancer incidence [Internet]. Goyang (KR): National Cancer Information Center; c2011 [cited 2012 Sep 15]. Available from: http://www.cancer.go.kr/ncic/cics_f/01/011/index.html.
- Lee CM, Szabo A, Shrieve DC, et al. Descriptive nomograms of adjuvant radiotherapy use and patterns of care analysis for stage I and II endometrial adenocarcinoma: a surveillance, epidemiology, and end results population study. Cancer 2007;110:2092-100. https://doi.org/10.1002/cncr.22997
- ASTEC/EN.5 Study Group, Blake P, Swart AM, et al. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet 2009;373:137-46. https://doi.org/10.1016/S0140-6736(08)61767-5
- Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet 2000;355:1404-11. https://doi.org/10.1016/S0140-6736(00)02139-5
- Scholten AN, van Putten WL, Beerman H, et al. Postoperative radiotherapy for stage 1 endometrial carcinoma: longterm outcome of the randomized PORTEC trial with central pathology review. Int J Radiat Oncol Biol Phys 2005;63:834-8. https://doi.org/10.1016/j.ijrobp.2005.03.007
- Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol 2004;92:744-51. https://doi.org/10.1016/j.ygyno.2003.11.048
- Aalders J, Abeler V, Kolstad P, Onsrud M. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol 1980;56:419-27.
- Scotti V, Borghesi S, Meattini I, et al. Postoperative radiotherapy in stage I/II endometrial cancer: retrospective analysis of 883 patients treated at the University of Florence. Int J Gynecol Cancer 2010;20:1540-8.
- Eiriksson L, Cuartero J, Steed H, et al. Assessment of outcomes in surgically staged I/II endometrial adenocarcinoma patients treated with postoperative vaginal vault radiotherapy only. Int J Gynecol Cancer 2010;20:1356-62.
- Randall ME, Filiaci VL, Muss H, et al. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 2006;24:36-44. https://doi.org/10.1200/JCO.2004.00.7617
- Maggi R, Lissoni A, Spina F, et al. Adjuvant chemotherapy vs radiotherapy in high-risk endometrial carcinoma: results of a randomised trial. Br J Cancer 2006;95:266-71. https://doi.org/10.1038/sj.bjc.6603279
- Susumu N, Sagae S, Udagawa Y, et al. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study. Gynecol Oncol 2008;108:226-33. https://doi.org/10.1016/j.ygyno.2007.09.029
- Greven K, Winter K, Underhill K, Fontenesci J, Cooper J, Burke T. Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer. Gynecol Oncol 2006;103:155-9. https://doi.org/10.1016/j.ygyno.2006.02.007
-
Hogberg T, Rosenberg P, Kristensen G, et al. A randomized phase-III study on adjuvant treatment with radiation (RT)
$\pm$ chemotherapy (CT) in early-stage high-risk endometrial cancer (NSGO-EC-9501/EORTC 55991) [abstract]. J Clin Oncol 2007;25(18S):5503. - US National Institute of Health. ClinicalTrials.gov [Internet]. Bethesda, MD: US National Institute of Health; c2012 [cited 2012 Sep 15]. Available from: http://clinicaltrials.gov/ct2/ home.
- Irwin C, Levin W, Fyles A, Pintilie M, Manchul L, Kirkbride P. The role of adjuvant radiotherapy in carcinoma of the endometrium-results in 550 patients with pathologic stage I disease. Gynecol Oncol 1998;70:247-54. https://doi.org/10.1006/gyno.1998.5064
- Uharcek P. Prognostic factors in endometrial carcinoma. J Obstet Gynaecol Res 2008;34:776-83. https://doi.org/10.1111/j.1447-0756.2008.00796.x
- Yalman D, Ozsaran Z, Anacak Y, et al. Postoperative radiotherapy in endometrial carcinoma: analysis of prognostic factors in 440 cases. Eur J Gynaecol Oncol 2000;21:311-5.
- Yoney A, Yildirim C, Bati Y, Unsal M. Low risk stage I endometrial carcinoma: prognostic factors and outcomes. Indian J Cancer 2011;48:204-10. https://doi.org/10.4103/0019-509X.82895
- Pessini SA, Zettler CG, Wender MC, Pellanda LC, Silveira GP. Survival and prognostic factors of patients treated for stage I to stage III endometrial carcinoma in a reference cancer center in Southern Brazil. Eur J Gynaecol Oncol 2007;28:48-50.
- Li J, Kong WM. Prognostic factors of stage III endometrial carcinoma. Zhonghua Yi Xue Za Zhi 2009;89:198-200.
- Grodin JM, Siiteri PK, MacDonald PC. Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab 1973;36:207-14. https://doi.org/10.1210/jcem-36-2-207
- Trabert B, Wentzensen N, Yang HP, et al. Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk? Int J Cancer 2012 May 3 [Epub]. http://dx.doi.org/10.1002/ijc.27623.
Cited by
- A multicenter analysis of adjuvant therapy after surgery for stage IIIC endometrial adenocarcinoma: A Korean Radiation Oncology Group study (KROG 13-17) vol.138, pp.3, 2012, https://doi.org/10.1016/j.ygyno.2015.06.030
- Adjuvant Treatment after Surgery in Stage IIIA Endometrial Adenocarcinoma vol.48, pp.3, 2012, https://doi.org/10.4143/crt.2015.356
- Analysis of postoperative radiotherapy effects within risk groups in patients with FIGO I, II, and III endometrial cancer vol.56, pp.4, 2012, https://doi.org/10.4103/ijc.ijc_370_18